Juno is racing the competitor, Kite Pharma, to launch CAR-T immunotherapy cancer treatment on the market.
Juno is racing the competitor, Kite Pharma, to launch CAR-T immunotherapy cancer treatment on the market.
↧
Juno stock hits highest mark in over a year after a competitor’s $12B acquisition
Juno is racing the competitor, Kite Pharma, to launch CAR-T immunotherapy cancer treatment on the market.
↧